MEDI-507 MEDI 507
We provide customized and high-quality Siplizumab product for your project.
Siplizumab is a humanized IgG1 monoclonal antibody directed against CD2. Siplizumab was shown to deplete T cells globally while promoting expansion of regulatory T cells early post-transplant. Siplizumab is under investigation as a tolerance induction agent in RTR.
About|Contact|Cas|Product Name|Molecular|Country|Encyclopedia
Message|New Cas|MSDS|Service|Advertisement|CAS DataBase|Article Data|Manufacturers | Chemical Catalog
©2008 LookChem.com,License: ICP
NO.:Zhejiang16009103
complaints:service@lookchem.com Desktop View